Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro

Di Shao; Emad Massoud; David Clarke; Elizabeth Cowley; Ken Renton; Remigius U. Agu

doi:10.1016/j.ijpharm.2012.11.023

Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro

Di Shao, Emad Massoud, David Clarke, Elizabeth Cowley, Ken Renton, Remigius U. Agu

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	334-342
Number of pages	9
Journal	International Journal of Pharmaceutics
Volume	441
Issue number	1-2
DOIs	https://doi.org/10.1016/j.ijpharm.2012.11.023
Publication status	Published - Jan 30 2013

ASJC Scopus Subject Areas

Pharmaceutical Science

Access to Document

10.1016/j.ijpharm.2012.11.023

Cite this

@article{a02985455b704ed9940f4968612b2417,

title = "Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro",

author = "Di Shao and Emad Massoud and David Clarke and Elizabeth Cowley and Ken Renton and Agu, {Remigius U.}",

note = "Funding Information: We thank Caren Wyse for liaison between QEII hospital and our laboratory, and Dr. Kerry Goralski for PCR instrumentation. Funding for this project was provided by Nova Scotia Health Research Foundation (MED-Project- 2008-4691 ).",

year = "2013",

month = jan,

day = "30",

doi = "10.1016/j.ijpharm.2012.11.023",

language = "English",

volume = "441",

pages = "334--342",

journal = "International Journal of Pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro

AU - Shao, Di

AU - Massoud, Emad

AU - Clarke, David

AU - Cowley, Elizabeth

AU - Renton, Ken

AU - Agu, Remigius U.

N1 - Funding Information: We thank Caren Wyse for liaison between QEII hospital and our laboratory, and Dr. Kerry Goralski for PCR instrumentation. Funding for this project was provided by Nova Scotia Health Research Foundation (MED-Project- 2008-4691 ).

PY - 2013/1/30

Y1 - 2013/1/30

UR - http://www.scopus.com/inward/record.url?scp=84872801814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872801814&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2012.11.023

DO - 10.1016/j.ijpharm.2012.11.023

M3 - Article

C2 - 23178597

AN - SCOPUS:84872801814

SN - 0378-5173

VL - 441

SP - 334

EP - 342

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

IS - 1-2

ER -

Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this